Codexis Inc

NASDAQ:CDXSUnited States

Codexis, Inc. is an enzyme engineering company. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high performance enzymes and other classes of proteins. It utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) therapeutics through an enzymatic route. It also uses the CodeEvolver platform technology to develop enzymes for the synthesis of nucleic acids, such as DNA/RNA, including enzymes utilized in its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Contact Information

Headquarters

200 Penobscot DrREDWOOD CITY, CA, United States 94063-4718

Phone

650-421-8100

Fax

302-655-5049

Executives

Independent Chairman of the Board

Byron Dorgan

President, Chief Executive Officer, Director

Stephen Dilly

Chief Financial Officer, Chief Accounting Officer

Sriram Ryali

Chief Operating Officer

Kevin Norrett

Chief Legal and Compliance Officer, General Counsel and Secretary

Margaret Fitzgerald